Revolution Medicines Inc (42Z)

Currency in EUR
29.80
-0.20(-0.67%)
Closed·
42Z is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.8030.60
52 wk Range
27.0058.50
Key Statistics
Bid/Ask
29.60 / 30.60
Prev. Close
30
Open
30.6
Day's Range
29.8-30.6
52 wk Range
27-58.5
Volume
39
Average Volume (3m)
171
1-Year Change
-20.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
42Z Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Revolution Medicines Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Revolution Medicines Inc Company Profile

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company’s RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Compare 42Z to Peers and Sector

Metrics to compare
42Z
Peers
Sector
Relationship
P/E Ratio
0.0x−4.0x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x2.5x2.6x
Price / LTM Sales
0.0x150.6x3.3x
Upside (Analyst Target)
0.0%187.1%43.5%
Fair Value Upside
Unlock6.5%6.8%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

42Z Income Statement

People Also Watch

247.45
AVAV
-4.68%
159.03
CRCL
+3.99%
46.630
ASTS
-2.26%
6.400
PL
+2.07%
60.87
TEM
+3.63%

FAQ

What Stock Exchange Does Revolution Medicines Inc Trade On?

Revolution Medicines Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Revolution Medicines Inc?

The stock symbol for Revolution Medicines Inc is "42Z."

What Is the Revolution Medicines Inc Market Cap?

As of today, Revolution Medicines Inc market cap is 5.62B.

What Is Revolution Medicines Inc's Earnings Per Share (TTM)?

The Revolution Medicines Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 42Z a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Revolution Medicines Inc Stock Split?

Revolution Medicines Inc has split 0 times.

What is the current trading status of Revolution Medicines Inc (42Z)?

As of 09 Aug 2025, Revolution Medicines Inc (42Z) is trading at a price of 29.80, with a previous close of 30.00. The stock has fluctuated within a day range of 29.80 to 30.60, while its 52-week range spans from 27.00 to 58.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.